Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen C Collins

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Bioconjugate Chemistry|February 14, 2014
Investigating hapten clustering as a strategy to enhance vaccines against drugs of abuseKaren C Collins, Kim D Janda
Journal of Medicinal Chemistry|April 8, 2016
Methamphetamine Vaccines: Improvement through Hapten DesignKaren C Collins, Joel E Schlosburg, Paul T Bremer, et al.
Tetrahedron|June 25, 2016
Dissecting AI-2-mediated quorum sensing through C5-analogue synthesis and biochemical analysisKaren C Collins, Kyoji Tsuchikama, Colin A Lowery, et al.
Angewandte Chemie (International Ed. in English)|February 17, 2016
Combatting Synthetic Designer Opioids: A Conjugate Vaccine Ablates Lethal Doses of Fentanyl Class DrugsPaul T Bremer, Atsushi Kimishima, Joel E Schlosburg, et al.
Organic Letters|June 24, 2014
Enzymatic glycosylation of vancomycin aglycon: completion of a total synthesis of vancomycin and N- and C-terminus substituent effects of the aglycon substrateAtsushi Nakayama, Akinori Okano, Yiqing Feng, et al.
Journal of Medicinal Chemistry|December 11, 2014
A conjugate vaccine using enantiopure hapten imparts superior nicotine-binding capacityJonathan W Lockner, Jenny M Lively, Karen C Collins, et al.
Journal of the American Chemical Society|March 10, 2015
Total syntheses and initial evaluation of [Ψ[C(═S)NH]Tpg⁴]vancomycin, [Ψ[C(═NH)NH]Tpg⁴]vancomycin, [Ψ[CH₂NH]Tpg⁴]vancomycin, and their (4-chlorobiphenyl)methyl derivatives: synergistic binding pocket and peripheral modifications for the glycopeptide antibioticsAkinori Okano, Atsushi Nakayama, Kejia Wu, et al.
Chemical Communications (Cambridge, England)|July 6, 2017
A bioconjugate leveraging xenoreactive antibodies to alleviate cocaine-induced behaviorNIcholas T Jacob, Kensaku Anraku, Atsushi Kimishima, et al.
Molecular Pharmaceutics|December 23, 2014
Flagellin as carrier and adjuvant in cocaine vaccine developmentJonathan W Lockner, Lisa M Eubanks, Jennifer L Choi, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Bioconjugate Chemistry|February 14, 2014
Investigating hapten clustering as a strategy to enhance vaccines against drugs of abuseKaren C Collins, Kim D Janda
Journal of Medicinal Chemistry|April 8, 2016
Methamphetamine Vaccines: Improvement through Hapten DesignKaren C Collins, Joel E Schlosburg, Paul T Bremer, et al.
Tetrahedron|June 25, 2016
Dissecting AI-2-mediated quorum sensing through C5-analogue synthesis and biochemical analysisKaren C Collins, Kyoji Tsuchikama, Colin A Lowery, et al.
Angewandte Chemie (International Ed. in English)|February 17, 2016
Combatting Synthetic Designer Opioids: A Conjugate Vaccine Ablates Lethal Doses of Fentanyl Class DrugsPaul T Bremer, Atsushi Kimishima, Joel E Schlosburg, et al.
Organic Letters|June 24, 2014
Enzymatic glycosylation of vancomycin aglycon: completion of a total synthesis of vancomycin and N- and C-terminus substituent effects of the aglycon substrateAtsushi Nakayama, Akinori Okano, Yiqing Feng, et al.
Journal of Medicinal Chemistry|December 11, 2014
A conjugate vaccine using enantiopure hapten imparts superior nicotine-binding capacityJonathan W Lockner, Jenny M Lively, Karen C Collins, et al.
Journal of the American Chemical Society|March 10, 2015
Total syntheses and initial evaluation of [Ψ[C(═S)NH]Tpg⁴]vancomycin, [Ψ[C(═NH)NH]Tpg⁴]vancomycin, [Ψ[CH₂NH]Tpg⁴]vancomycin, and their (4-chlorobiphenyl)methyl derivatives: synergistic binding pocket and peripheral modifications for the glycopeptide antibioticsAkinori Okano, Atsushi Nakayama, Kejia Wu, et al.
Chemical Communications (Cambridge, England)|July 6, 2017
A bioconjugate leveraging xenoreactive antibodies to alleviate cocaine-induced behaviorNIcholas T Jacob, Kensaku Anraku, Atsushi Kimishima, et al.
Molecular Pharmaceutics|December 23, 2014
Flagellin as carrier and adjuvant in cocaine vaccine developmentJonathan W Lockner, Lisa M Eubanks, Jennifer L Choi, et al.
Pageof 1